Trial NCT02263508

View at ClinicalTrials.gov 
Org. Study IDs: 20110265
Secondary IDs: 2014-000185-22 KEYNOTE-034

Last trial update was posted on 2022-11-14

MeSH Interventions

Pembrolizumab Talimogene laherparepvec

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID